FGF19 and primary biliary cholangitis: To determine whether the hepatic FGF19-Src-FXR signaling pathway is impaired in PBC patients, we examined hepatic expression of FXR, SRC, and the FGF19 receptor complex, FGFR4 and βKL in 15 normal subjects and PBC patients.